IECM
TMO icon

Intrinsic Edge Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Intrinsic Edge Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-3,000
Closed -$851K – 256
2020
Q1 		$851K Buy
+3,000
New +$946K 0.11% 141

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Intrinsic Edge Capital Management's TMO Position: Q2 2020 in Review

Intrinsic Edge Capital Management sold out of Thermo Fisher Scientific (TMO) in Q2 2020, closing a stake of 3,000 shares — an estimated $851K sold.

Intrinsic Edge Capital Management first reported a position in TMO in Q1 2020 and held it in 1 quarter. The position peaked at $851K in Q1 2020. 1,748 funds tracked by Wall St. Rank hold TMO as of Q2 2020.

  • Intrinsic Edge Capital Management reported no remaining Thermo Fisher Scientific position as of Q2 2020 after selling out during the quarter.
  • Intrinsic Edge Capital Management sold 3,000 Thermo Fisher Scientific shares in Q2 2020, an estimated $851K.
  • Intrinsic Edge Capital Management first reported a position in Thermo Fisher Scientific in Q1 2020 and held it in 1 quarter.
  • Intrinsic Edge Capital Management's Thermo Fisher Scientific position peaked at $851K in Q1 2020.
  • 1,748 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2020.

Based on Intrinsic Edge Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.